Psychosis, Treatment Emergent Extrapyramidal Events, and Subsequent Onset of Huntington’s Disease: A Case Report and Review of the Literature
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disease characterized by a triad of progressive motor dysfunction, cognitive decline and psychiatric disturbances. The hallmark of HD is the distinctive choreiform movement disorder that typically has a subtle, insidious onset in the fourth to fifth decade of life and gradually worsens over 10 to 20 years until death. Notably, two-thirds of HD patients present with chorea and one third with mental changes. The prevalence of psychiatric symptoms is significantly higher than in the general population, and is estimated to be around 66-73%. Here, we report a unique case of subsequent onset of HD in a patient previously treated for schizophrenia and complicated by the extrapyramidal side effects to antipsychotics.
Abstract
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disease characterized by a triad of progressive motor dysfunction, cognitive decline and psychiatric disturbances. The hallmark of HD is the distinctive choreiform movement disorder that typically has a subtle, insidious onset in the fourth to fifth decade of life and gradually worsens over 10 to 20 years until death. Notably, two-thirds of HD patients present with chorea and one third with mental changes. The prevalence of psychiatric symptoms is significantly higher than in the general population, and is estimated to be around 66-73%. Here, we report a unique case of subsequent onset of HD in a patient previously treated for schizophrenia and complicated by the extrapyramidal side effects to antipsychotics.
참고문헌 (18)
- Lembert MV, "Epilepsy, Tourette’s syndrome and Huntington’s disease", Med Personal Subscr, 32, pp.48~50 (2004)
- Ross CA, "Huntington’s disease", Clin Neurosci Res, 1, pp.142~152 (2001)
- Tabrizi SJ, "Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data", Lancet Neurol, 8, pp.791~801 (2009)
- Quintanilla RA, "Role of mitochondrial dysfunction in the pathogenesis of Huntington’s disease", Brain Res Bull, 80, pp.242~247 (2009)
- Robins Wahlin TB, "To know or not to know: a review of behaviour and suicidal ideation in preclinical Huntington’s disease", Patient Educ Couns, 65, pp.279~287 (2007)
- MacDonald ME, "A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes", Cell, 72, pp.971~983 (1993), The Huntington’s Disease Collaborative Research Group
- van Duijn E, "Psychopathology in verified Huntington’s disease gene carriers", J Neuropsychiatry Clin Neurosci, 19, pp.441~448 (2007)
- Naarding P, "Huntington’s disease:a review of the literature on prevalence and treatment of neuropsychiatric phenomena", Eur Psychiatry, 16, pp.439~445 (2001)
- Duff K, ""Pre-symptomatic"Huntington’s disease", Handb Clin Neurol, 89, pp.589~598 (2008)
- Jauhar S, "Psychiatric and behavioural manifestations of Huntington’s disease", Adv Psychiatr Treat, 16, pp.168~175 (2010)
- Rosenblatt A, "Neuropsychiatry of Huntington’s disease and other basal ganglia disorders", Psychosomatics, 41, pp.24~30 (2000)
- Corrêa BB, "Association of Huntington’s disease and schizophrenia-like psychosis in a Huntington’s disease pedigree", Clin Pract Epidemiol Ment Health, 2, pp.1~ (2006)
- Mendez MF, "Huntington’s disease: update and review of neuropsychiatric aspects", Int J Psychiatry Med, 24, pp.189~208 (1994)
- Cubo E, "Effect of donepezil on motor and cognitive function in Huntington disease", Neurology, 67, pp.1268~1271 (2006)
- Nance M, "A physician’s guide to the management of Huntington’s disease", Huntington’s Disease Society of America, ~ (2011)
- Walker FO, "Huntington’s disease", Lancet, 369, pp.218~228 (2007)
- Landwehrmeyer GB, "Riluzole in Huntington’s disease: a 3-year, randomized controlled study", Ann Neurol, 62, pp.262~272 (2007)
- Lishman WA, "Organic psychiatry: The psychological consequences of cerebral disorder" (1998), Blackwell Publishing Company